Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/11118
DC FieldValueLanguage
dc.contributor.authorTatjana Milenkovicen_US
dc.contributor.authorMirjana Kocovaen_US
dc.contributor.authorBrankica Krstevskaen_US
dc.contributor.authorGordana Pemovskaen_US
dc.contributor.authorIvica Smokovskien_US
dc.date.accessioned2021-03-22T10:18:57Z-
dc.date.available2021-03-22T10:18:57Z-
dc.date.issued2016-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/11118-
dc.language.isoenen_US
dc.publisherMary Ann Lieberten_US
dc.relation.ispartofDiabetes Technology & Therapeuticsen_US
dc.titleComment on Publications from OpT2mise Studyen_US
dc.typeArticleen_US
dc.identifier.doi10.1089/dia.2016.0064-
dc.identifier.volume18-
dc.identifier.issue7-
item.grantfulltextnone-
item.fulltextNo Fulltext-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
Appears in Collections:Faculty of Medicine: Journal Articles
Show simple item record

Page view(s)

110
checked on Apr 28, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.